Slideshow
Author(s):
Findings from a new study indicate that compared with children who were not exposed to the drug, children with in utero exposure to sodium valproate have lower scores on national tests at age 7 years.
Shionogi Initiates First-Ever Human Study Testing Therapy for Ultra-Rare Jordan Syndrome
Episode 133: Clinical Guidance on Neuromodulation for Lennox-Gastaut Syndrome
New Open-Label Data Highlights Therapeutic Potential of Bexicaserin in Developmental and Epileptic Encephalopathies
Neurology Unwrapped: 2024’s Most Intriguing Conversations
The Female Leaders Who Shaped an Epilepsy Icon: Reflections From Jacqueline A. French, MD
This Week on NeurologyLive® — February 3, 2024